Deutsche Bank
http://www.db.com/
Deutsche Bank is a leading global investment bank with a strong and profitable private clients franchise.
The company operates through three divisions: Corporate and Investment Bank (CIB), Private Clients and Asset Management (PCAM) and Corporate Investments (CI) . The CIB division engages in the origination, sale, financing, structuring, and trading of fixed income, equity, equity-linked, convertible bond, foreign exchange, and commodities products. The PCAM segment provides portfolio/fund management products, including active fund management, passive/quantitative fund management, alternative investments, and discretionary portfolio management solutions in Germany and other continental European countries.-
-
-
-
-
-
-
Notable Analyst Rating Changes 4/29: (ALXN) (WNS) (CE) Upgraded; (WYNN) (SRPT) (DB) Downgraded
-
-
-
-
-
-
-
Sarepta Therapeutic (SRPT) Has 100% Upside, 50% Downside - Deutsche Bank
-
-
-
-
-
-
-
Streetinsider.com's Hot Lunchtime Reads 07/10: (CYNK) (MSFT) (SRPT) (CYTK)
-
-
-
-
-
-
-
Notable Analyst Rating Changes 01/06: (SCTY) (BSX) (AIG) Upgraded; (TWTR) (AAPL) (SRPT) Downgraded
-
-
-
-
-
-
-
Unusual 11 Mid-Day Movers 09/20: (RVP) (VRNM) (CYCC) Higher; (RNA) (FRO) (EMMS) Lower
-
-
-
-
-
-
-
Sarepta (SRPT) Management Firm on Eteplirsen Guidance, Robert Baird Says
-
-
-
-
-
-
-
Deutsche Bank Starts Sarepta Therapeutic (SRPT) at Buy; Could Be Worth Up to $71/Sh
-
55,975 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

